The upstream bioprocessing market is experiencing unprecedented growth, driven by a confluence of factors that are reshaping the landscape of biopharmaceutical production. Valued at 22.79 billion USD in 2023, the market is projected to surge to 82.10 billion USD by 2032, expanding at a compound
Recent findings have shed light on the pivotal role of fibroblastic reticular cells (FRCs) in enhancing the immune response within lung cancer tumors, particularly non-small cell lung cancer (NSCLC). These specialized cells create environments that bolster T-cell activity, potentiating anti-tumor
Psoriasis is a chronic inflammatory skin disease that affects millions of people worldwide. Recent research published in JAMA Dermatology has shed light on the potential link between the consumption of ultra-processed foods (UPFs) and the severity of active psoriasis. This study suggests that diet
The Philippine Cancer Center (PCC) has launched its National Cancer Research Agenda for 2024-2028, marking a significant step towards unified cancer prevention strategies and cohesive efforts to combat the disease in the country. The event, held on November 27, 2024, at Century Park Hotel in
Amid a rapidly evolving landscape where the demand for precision and efficiency in laboratory automation technology continues to grow, Advanced Automation Technologies (AAT) is poised to acquire GERSTEL GmbH & Co. KG and its international subsidiaries. This acquisition represents a significant step
Recent advancements in the field of cancer immunotherapy have unveiled an exciting discovery that involves the molecule MR1 and vitamin B6. Researchers at Monash University Biomedicine Discovery Institute, in collaboration with the University of Melbourne, have found that MR1 can bind to a form of
Prostate cancer remains the most common cancer in men, presenting significant challenges for healthcare systems worldwide. The journey for a prostate cancer patient is often fraught with difficult choices and life-altering treatments. However, recent advancements in medical technology and
The collaboration between Steritas LLC and argenx marks a significant milestone in the quest to revolutionize steroid-sparing treatments. This partnership aims to address the detrimental impact of long-term steroid use and explore innovative approaches to mitigate these effects. By leveraging
The growing disparities in cancer treatment between high- and low-income countries are becoming more pronounced, with significant inequalities in the cost and availability of cancer drugs globally. Predictions indicate that by 2040 the world will witness an estimated 28.4 million new cancer cases
Congenital heart disease (CHD) is a significant cause of infant morbidity and mortality, characterized by structural abnormalities in the heart or great vessels present at birth. This article delves into the clinical features, genetic characteristics, and pregnancy outcomes of 471 cases of fetal
